These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12073624)

  • 1. [Significance of parenteral iron administration for HCV-positive hemodialysis patients].
    Kurihara I; Saito T
    Nihon Jinzo Gakkai Shi; 2002 May; 44(4):389-95. PubMed ID: 12073624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron attenuates postvaccination anti-HBsAg titres after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapy.
    Liu JH; Liu YL; Lin HH; Yang YF; Kuo HL; Lin PW; Huang CC
    Int J Clin Pract; 2009 Mar; 63(3):387-93. PubMed ID: 18410348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
    Raja R; Bloom E; Goldstein M; Johnson R
    ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
    Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
    Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin.
    Aggarwal HK; Nand N; Singh S; Singh M; Hemant ; Kaushik G
    J Assoc Physicians India; 2003 Feb; 51():170-4. PubMed ID: 12725261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusting i.v. iron and EPO doses in patients on hemodialysis prior to continuing surgery: can we protect our patients education from iron-deficiency anemia?
    Deaver K; Bennington L
    Nephrol Nurs J; 2006; 33(4):430-7; quiz 438. PubMed ID: 17002001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
    Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
    Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.
    Ozdemir A; Yalinbaş B; Selamet U; Eres M; Murat B; Gürsu RU; Barut Y
    Nephrology (Carlton); 2005 Oct; 10(5):433-7. PubMed ID: 16221090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin.
    Ahsan N; Groff JA; Waybill MA
    Adv Perit Dial; 1996; 12():161-6. PubMed ID: 8865893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retardation of hemodialysis by recombinant human erythropoietin in patients with chronic kidney disease].
    Kato F; Takeuchi N; Takenoshita E; Yuasa J; Isaka S; Fujii T; Suzuki S; Irie Y; Ogawa M; Ueda S
    Nihon Jinzo Gakkai Shi; 2010; 52(1):58-65. PubMed ID: 20166543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of erythropoietin with oral iron in peritoneal dialysis and hemodialysis patients.
    Raja R; Bloom E; Johnson R
    Adv Perit Dial; 1993; 9():177-80. PubMed ID: 8105918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible influence of vitamin D receptor gene polymorphisms on recombinant human erythropoietin requirements in dialysis patients.
    Sezer S; Tutal E; Bilgic A; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):40-4. PubMed ID: 17275471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.